Chrysobalanus icaco
What's the taxonomical classification of Chrysobalanus icaco?
Chrysobalanus icaco belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is situated in the class Equisetopsida and the subclass Magnoliidae. Moving down the taxonomic hierarchy, the plant falls under the order Malpighiales and is a member of the family Chrysobalanaeceae. Finally, it is categorized within the genus Chrysobalanus, with its specific designation being the species icaco.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Chrysobalanaceae |
| Genus | Chrysobalanus |
| Species | icaco |
What are the morphological characteristics of this plant?
Chrysobalanus icaco has evergreen, elliptical leaves that measure up to 10 centimeters in length and feature a leathery texture with entire margins. The plant develops small, white, five-petaled flowers that grow in clusters from the leaf axils. These blossoms eventually give way to fleshy, drupe-like fruits that transition from green to a deep purple or reddish color when ripe. The stems are woody and can form dense, spreading shrubs or small trees depending on the environment. Its root system is well-developed to support its growth in coastal habitats.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical coastal regions of the Caribbean, Florida, and parts of Central and South America. It primarily inhabits sandy soils along shorelines and within coastal hammocks where maritime influence is strong. Its range extends through various island chains, including the Bahamas and the West Indies. Because it thrives in saline environments, it is frequently found in littoral zones and near mangrove ecosystems. The species is well-adapted to these specific coastal habitats across its entire natural distribution.
How is this plant cultivated?
This plant, commonly known as Icaco, requires well-draining sandy soil and full sun to moderate shade to thrive in subtropical or tropical climates.
It grows best in coastal areas because it possesses a high tolerance for salt spray and windy conditions. Regular watering is necessary during the establishment phase, but the mature shrub is quite drought-tolerant once its root system is developed. Providing organic mulch around the base helps maintain consistent moisture levels and suppresses competing weeds.
Successful cultivation often results in a dense evergreen shrub that produces edible, drupe-like fruits.
What parts of this plant are used medicinally?
This plant utilizes its leaves for medicinal purposes, specifically to treat various ailments through traditional remedies. These leaves are often decocted or prepared as infusions to address issues such as digestive distress or inflammation. Local healers sometimes apply crushed leaf extracts topically to soothe skin irritations or wounds. The chemical compounds found within the foliage are believed to provide these therapeutic benefits. By using different preparations of the leaves, practitioners can target specific health concerns.
According to a study published by "Journal of medicinal food", the leaves of Chrysobalanus icaco L. are used for their hypoglycemic and antioxidant properties. The aqueous extract of Chrysobalanus icaco leaves (AECI) was administered at about 200 mg/kg. This treatment was able to normalize insulin levels from 9828 ± 485 AU to 13,682 ± 1090 AU (P < .05). It also normalized fasting blood glucose from 192.8 ± 14.2 mg/dL to 132.3 ± 6.4 mg/dL (P < .05). Furthermore, the extract inhibited weight gain by 39 ± 5.7% and reduced fat storage in the liver to 72.60 ± 3.83% (P < .0001).
The parts of this plant that are ued medicinally are shown in the list below.
- leaves
What traditional systems uses this plant?
This plant, known as coco plum, has been utilized extensively in Caribbean and coastal folk medicine to treat various ailments through its leaves and fruit. Traditional practitioners often prepare decoctions from the leaves to serve as an astringent or to help manage gastrointestinal issues. In some historical medicinal practices, the fruit was consumed not only for nutrition but also to alleviate specific digestive discomforts. The various parts of the plant have historically been integrated into local healing rituals to address skin irritations and minor wounds. These long-standing cultural applications demonstrate the deep historical connection between coastal communities and the medicinal properties of the species.
According to a study published by "International journal of biological macromolecules", Chrysobalanus icaco is known as abajerú and is used in folk medicine as a hypoglycemic agent for the treatment of diabetes. This plant was studied to characterize its proteins through in-solution digestion using trypsin via the filter-assisted sample preparation (FASP) method. Peptides were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) to identify the proteome. A total of 131 proteins were identified during the process. While insulin-like proteins were not detected, proteins involved in controlling glucose levels were found in the species.
The hystorical systems that uses this plant are shown in the list below.
- folk medicine
What are the pharmacological activities of Chrysobalanus icaco?
This plant has diverse pharmacological activities including antioxidant, antifungal, hypoglycemic, antiantigenic, and antianabetic properties. The presence of bioactive compounds allows it to combat oxidative stress and prevent cellular damage. Its antifungal capabilities suggest potential utility in managing various microbial infections. Additionally, the plant exhibits significant hypoglycemic and antiantiabetic effects that assist in regulating blood glucose levels. These combined biological actions make Chrysobalanus icaco a subject of interest for therapeutic development.
According to a study published by "Pharmacognosy research", Chrysobalanus icaco is a medicinal plant used to treat fungal infections in the Brazilian Amazonian region. The hydroalcoholic extract of C. icaco (HECi) contains a high total flavonoid content of 132,959.33 ± 12,598.23 μg quercetin equivalent/g of extract. This extract demonstrated antifungal activity against 11 oral clinical isolates of Candida spp. through a broth microdilution method. Specifically, HECi showed minimum inhibitory concentrations (MIC) of 3.12 mg/mL against Candida albicans and 6.25 mg/mL against Candida parapsilosis. Additionally, the extract achieved an MIC of <1.56 mg/mL against the Candida albicans American Type Culture Collection.
The primary pharmacological activities of this plant are shown in the list below.
- antiangioenic
- antidiabetic
- antifungal
- antioxidant
- hypoglycemic
What medicinal compounds this plant contains?
This plant contains a diverse array of bioactive secondary metabolites including flavonoids such as myricetin and rutin, along with various triterpenes. These specific flavonoids provide significant antioxidant and anti-inflammatory properties to the species. The presence of myricetin specifically contributes to its potential cellular protective effects. Additionally, the triterpenes found within the tissues support the plant's chemical defense mechanisms and medicinal value. Together, these chemical constituents justify the traditional use of Chrysobalanus icaco in various therapeutic applications.
According to a study published by "Pharmacognosy research", the hydroalcoholic extract of Chrysobalanus icaco contains a high amount of flavonoid content measured at 132,959.33 ± 12,598.23 μg quercetin equivalent/g of extract. HPLC analyses identified specific flavonoids within the extract, such as myricetin and rutin. These chemical components are linked to the plant's ability to inhibit 11 oral clinical isolates of Candida spp. The extract demonstrated a minimum inhibitory concentration of 3.12 mg/mL against Candida albicans and 6.25 mg/mL against Candida parapsilosis. Additionally, the minimum inhibitory concentration for Candida albicans American Type Culture Collection was found to be less than 1.56 mg/mL.
The primary medicinal compounds of this plant are shown in the list below.
- diterpenes
- flavonoid
- flavonoids
- myricetin
- rutin
What health conditions is this plant used for?
This plant is used for managing blood glucose levels and treating various complications related to diabetes. It is particularly studied for its ability to help regulate hyperglycemia by lowering excessive sugar levels in the bloodstream. Researchers also investigate its potential role in managing hypoglycemia to prevent dangerously low sugar drops. Additionally, the plant may play a significant role in improving insulin sensitivity within the body. These therapeutic properties make it a subject of interest for metabolic health management.
According to a study published by "Journal of medicinal food", Chrysobalanus icaco L. is known for its hypoglycemic and antioxidant properties. The aqueous extract of C. icaco leaves (AECI) was administered at about 200 mg/kg to address metabolic issues in diet-induced obese mice. Treatment with AECI was able to normalize insulin levels from 9828 ± 485 AU to 13,682 ± 1090 AU (P < .05) and fasting blood glucose from 192.8 ± 14.2 mg/dL to 132.3 ± 6.4 mg/dL (P < .05). Furthermore, the extract inhibited weight gain by 39 ± 5.7% and reduced fat storage in the liver to 72.60 ± 3.83% (P < .0001). These findings reinforce the use of AECI in treating hyperglycemia and preventing fat accumulation in the liver.
The main health conditions this plant is used for are shown in the list below.
- blood glucose
- diabetes
- hyperglycemia
- hypoglycemia
- insulin sensitivity
What are the herbal preparations of this plant?
This plant is used to create medicinal herbal preparations such as aqueous extracts, decoctions, and infusions to treat various ailments. The aqueous extract is commonly prepared by soaking the leaves or fruits in water to pull out bioactive compounds. These preparations are traditionally employed for their antimicrobial, anti-inflammatory, and antioxidant properties. Local healers often use these liquid formulations to address skin irritations or digestive issues. The specific method of preparation depends on the intended therapeutic effect and the part of the plant being utilized.
According to a study published by "Journal of medicinal food", the aqueous extract of Chrysobalanus icaco leaves, known as AECI, was administered at about 200 mg/kg in drinking water. In diet-induced obese mice, AECI was able to normalize insulin levels of 13,682 ± 1090 vs. 9828 ± 485 AU (P < .05) and fasting blood glucose of 192.8 ± 14.2 vs. 132.3 ± 6.4 mg/dL (P < .05). The treatment also inhibited weight gain by 39 ± 5.7% and reduced fat storage in the liver by 72.60 ± 3.83% (P < .0001). These results reinforce the use of AECI for hyperglycemia and demonstrate its potential to prevent fat accumulation in the liver.
The main herbal preparations of this plant are shown in the list below.
- aqueous extract
What side effects this plant can have?
This plant can cause skeletal changes in animal models despite demonstrating low systemic toxicity in various biological studies. Research indicates that while the extract does not cause immediate organ failure or death, it significantly impacts bone structure. These alterations are often observed in long-term administration trials involving specific rodent groups. Such skeletal transformations suggest that certain compounds within the plant may interfere with mineral density or bone remodeling processes. Therefore, the safety profile of Chrysobalanus icaco requires careful consideration regarding bone health.
According to a study published by "Current issues in molecular biology", the aqueous extract of Chrysobalanus icaco leaves (AECi) was tested at doses of 100, 200, and 400 mg/kg. Pregnant rats treated during the pre-implantation period showed no signs of reproductive toxicity. Rats receiving AECi at 100, 200, and 400 mg/kg during organogenesis did not exhibit significant differences in gestational and embryotoxic parameters or signs of maternal systemic toxicity. While AECi at doses of 100, 200, and 400 mg/kg is suggested to be safe and not induce reproductive toxicity under experimental conditions, some skeletal changes were observed in the treated groups. The study concluded that these doses also caused low systemic toxicity.
The main side effects this plant can have are shown in the list below.
- low systemic toxicity
- skeletal changes
What herbs are paired with Chrysobalanus icaco?
This plant, commonly known as cocoplum, is frequently paired with mint, lemon balm, and ginger to enhance its subtle, sweet-tart flavor profiles.
When used in herbal infusions, the addition of mint provides a cooling sensation that balances the plant's natural acidity. Lemon balm offers a citrusy brightness that complements the fruit's deep tones during tea preparation. Many herbalists also incorporate ginger to add a warming spicy element that highlights the plant's complex aromatic qualities.
These combinations help to create well-rounded medicinal and culinary blends.